Clinical Trial Update: Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Bepotastine Besilate Ophthalmic Solution for allergic conjunctivitis has completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Bepotastine Besilate Ophthalmic Solution (bepotastine besilate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2012-03-26